Literature DB >> 27151982

Reverse Translation in Parkinson Disease.

Roger L Albin1, Kirk A Frey2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27151982      PMCID： PMC5367440          DOI： 10.2967/jnumed.116.175257

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  11 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Authors:  Yilong Ma; Chengke Tang; Phoebe G Spetsieris; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-28       Impact factor: 6.200

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.

Authors:  Shichun Peng; Yilong Ma; Joseph Flores; Michael Cornfeldt; Branka Mitrovic; David Eidelberg; Doris J Doudet
Journal:  J Nucl Med       Date:  2016-04-07       Impact factor: 10.057

5.  Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

Authors:  Robert E Gross; Raymond L Watts; Robert A Hauser; Roy Ae Bakay; Heinz Reichmann; Rüdiger von Kummer; William G Ondo; Elke Reissig; Wilhelm Eisner; Heike Steiner-Schulze; Harald Siedentop; Klaus Fichte; Walter Hong; Michael Cornfeldt; Katherine Beebe; Rupert Sandbrink
Journal:  Lancet Neurol       Date:  2011-05-10       Impact factor: 44.182

6.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

7.  Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.

Authors:  Madhavi Tripathi; Chris C Tang; Andrew Feigin; Ivana De Lucia; Amir Nazem; Vijay Dhawan; David Eidelberg
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

8.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

9.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

10.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.